Susquehanna International Group, LLP Cellectis S.A. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Cellectis S.A. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 13,010 shares of CLLS stock, worth $25,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,010

Previous 16,800 22.56%

Holding current value

$25,499

Previous $31,000 12.9%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.9 - $2.4 $24,719 - $31,224	13,010 New	13,010 $27,000
Q1 2024 May 07, 2024	BUY	$2.41 - $3.09 $19,595 - $25,124	8,131 Added 41.65%	27,655 $73,000
Q4 2023 Feb 14, 2024	BUY	$0.97 - $3.55 $18,938 - $69,310	19,524 New	19,524 $60,000
Q4 2022 Feb 14, 2023	BUY	$1.85 - $2.6 $107,460 - $151,026	58,087 New	58,087 $121,000
Q4 2021 Feb 14, 2022	BUY	$8.01 - $12.84 $89,471 - $143,422	11,170 Added 100.48%	22,287 $181,000
Q3 2021 Nov 15, 2021	SELL	$11.94 - $16.09 $138,014 - $185,984	-11,559 Reduced 50.97%	11,117 $140,000
Q2 2021 Aug 11, 2021	SELL	$14.36 - $20.93 $252,692 - $368,305	-17,597 Reduced 43.69%	22,676 $351,000
Q1 2021 May 17, 2021	SELL	$18.19 - $33.25 $97,280 - $177,821	-5,348 Reduced 11.72%	40,273 $814,000
Q4 2020 Feb 16, 2021	BUY	$15.87 - $31.64 $305,735 - $609,544	19,265 Added 73.1%	45,621 $1.23 Million
Q4 2019 Feb 14, 2020	BUY	$9.73 - $19.31 $256,443 - $508,934	26,356 New	26,356 $451,000
Q3 2019 Nov 14, 2019	SELL	$10.15 - $16.89 $146,271 - $243,401	-14,411 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$14.6 - $20.6 $42,880 - $60,502	2,937 Added 25.6%	14,411 $225,000
Q2 2019 Aug 14, 2019	SELL	$14.6 - $20.6 $36,135 - $50,985	-2,475 Reduced 17.74%	11,474 $179,000
Q1 2019 May 15, 2019	SELL	$15.53 - $19.75 $143,388 - $182,351	-9,233 Reduced 39.83%	13,949 $256,000
Q3 2018 Nov 14, 2018	SELL	$25.99 - $30.6 $249,685 - $293,974	-9,607 Reduced 29.3%	23,182 $654,000
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $111,175 - $154,197	4,002 Added 13.9%	32,789 $928,000
Q1 2018 May 15, 2018	SELL	$27.78 - $35.19 $1,666 - $2,111	-60 Reduced 0.21%	28,787 $907,000
Q4 2017 Feb 14, 2018	BUY	$23.33 - $35.01 $146,092 - $219,232	6,262 Added 27.73%	28,847 $841,000
Q3 2017 Nov 14, 2017	BUY	$21.65 - $32.18 $488,965 - $726,785	22,585	22,585 $643,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

5.9K

Put Options Held

1.4K

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $89.2M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cellectis S.A. Transaction History